Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Saved in:
| Title: | Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions. |
|---|---|
| Authors: | Rashedi S; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Leyva H; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hamade N; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Pfeferman MB; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ortega-Paz L; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA., Sadeghipour P; Vascular Disease and Thrombosis Research Center, Rajaie Cardiovascular Institute, Tehran, Iran; Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran., Talasaz AH; Department of Pharmacotherapy & Outcomes Sciences, Virginia Commonwealth University, Richmond, Virginia, USA; Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Long Island University, New York, New York, USA; Department of Pharmacy, New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA., O'Donoghue ML; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jimenez D; Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain; Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain., Monreal M; Thromboembolic Disorders, Facultad de Medicina, Universidad Catolica San Antonio de Murcia, Murcia, Spain., Anderson CD; Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, Massachusetts, USA; McCance Center for Brain Health, Mass General Brigham, Boston, Massachusetts, USA; Department of Neurology, Mass General Brigham, Boston, Massachusetts, USA., Elkind MSV; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA., Lang IM; Department of Internal Medicine II, Cardiology and Center of Cardiovascular Medicine, Medical University of Vienna, Vienna, Austria., Weitz JI; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; Department of Medicine and Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada., Goldhaber SZ; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., De Caterina R; University Cardiology Division, Pisa University Hospital, Pisa, Italy; Postgraduate School of Cardiology, University of Pisa, Pisa, Italy; Fondazione Villa Serena per la Ricerca, Città Sant'Angelo, Pescara, Italy., Konstantinides SV; Center for Thrombosis and Haemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece., Piazza G; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Krumholz HM; YNHH/ Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA., Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bikdeli B; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; YNHH/ Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA. Electronic address: bbikdeli@bwh.harvard.edu. |
| Source: | Journal of the American College of Cardiology [J Am Coll Cardiol] 2025 Oct 07; Vol. 86 (14), pp. 1065-1087. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
